2019-08-22 10:24
FDA accepts Bausch Health application for acne lotion. The FDA has accepted for review Bausch Health Companies (NYSE:BHC) unit Ortho Dermatologics' marketing application for IDP-123 (tazarotene 0.045%) Lotion for the treatment of acne. The agency's action date is December 22.只是接受了申请,反馈时间是12月22。不至于是那么重大的利好吧?而且我们也经历过,FDA通过了哪个药,结果一周内跌了10%。好像是去年年初?